ArticleMolecular therapy. Nucleic acids2026

DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model.

Linda Sasset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.